Streetbeat News

Equity Actions

ARDT

Ardent Health Partners (ARDT) opened at $15 per share, below its IPO price of $16.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 4:40 pm

LGVN

Longeveron shares are trading lower following the announcement of a $9.0 million registered direct offering of 2.2 million shares of its common stock at $4.025 per share.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 4:22 pm

RDZN

Roadzen shares are trading lower after the company announced that the CEO and Chairman agreed to exchange $3.5 million of short-term debt for equity.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 4:19 pm

TCRT

Alaunos Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 4:13 pm

TWFG

TWFG's IPO shares opened for trade at $22 per share, significantly higher than the IPO price of $17 per share.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 4:09 pm

CLSK

Significant options activity has been detected for Cleanspark (NASDAQ:CLSK), with a notable amount of bullish sentiment. Large investors have been targeting a price range of $7.0 to $37.0 for CLSK over the last three months. The stock is currently down 9.09% at $17.34, with analysts setting an average target price of $27.5.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 3:47 pm

RDZN

Roadzen's CEO and Chairman will exchange $3.5 million of short-term debt for company equity, potentially strengthening the company's balance sheet and aligning executive interests with shareholders.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 3:23 pm

OPK

Opko Health, Inc. (NASDAQ:OPK) shares are trading higher after announcing a $100 million share repurchase program and a $250 million non-dilutive note purchase agreement with HealthCare Royalty. The stock is trading above its 50-day moving average and has seen a recent rise in price.

Portfolio Pulse from Erica Kollmann

July 18, 2024 | 3:13 pm

ARTV

Artiva Biotherapeutics, Inc (NASDAQ:ARTV) is set to start trading on the NASDAQ exchange on July 19. The IPO price is expected to be between $14.00 and $16.00 per share, with an insider lock-up period of 180 days ending on January 15, 2025. Artiva is a clinical-stage biotechnology company focused on NK cell-based therapies for autoimmune diseases and cancers.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 3:00 pm

QMMM

QMMM Holdings Limited (NASDAQ:QMMM) is set to IPO on July 19 on the NASDAQ exchange with shares priced at $4.00 each. The insider lock-up period will end on January 15, 2025. The company provides digital media advertising and marketing production services.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 3:00 pm